During the past decade, Dokuz Eylul University Medical Faculty conducted 60 clinical trials. In the 10-year time frame, 60 clinical trials started and 19 clinical trials were completed, i.e. on average, 31.7% percent of trials that started reached the finish line to date. In the past 5 years, 30 clinical trials started and 12 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dokuz Eylul University Medical Faculty" #1 sponsor was "Janssen Research & Development, LLC" with 18 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 8 trials sponsored, "Bayer" with 5 trials sponsored, "Pfizer" with 4 trials sponsored and "Alexion" with 4 trials sponsored. Other sponsors include 34 different institutions and companies that sponsored additional 35 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dokuz Eylul University Medical Faculty" #1 collaborator was "Takeda Development Center Americas, Inc." with 3 trials as a collaborator, "Janssen Research & Development, LLC" with 2 trials as a collaborator, "Klinar CRO" with 2 trials as a collaborator, "Pharmacyclics LLC." with 2 trials as a collaborator and "argenx" with 2 trials as a collaborator. Other collaborators include 23 different institutions and companies that were collaborators in the rest 33 trials.

According to Clinical.Site data, the most researched conditions in "Dokuz Eylul University Medical Faculty" are "Multiple Myeloma" (7 trials), "Bladder Cancer" (3 trials), "Heart Failure" (3 trials), "Blood Transfusion" (2 trials) and "Cardiovascular Disease" (2 trials). Many other conditions were trialed in "Dokuz Eylul University Medical Faculty" in a lesser frequency.

Most popular intervention types in "Dokuz Eylul University Medical Faculty" are "Drug" (52 trials), "Biological" (10 trials), "Other" (10 trials), "Procedure" (5 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "Dexamethasone" (7 trials), "Bortezomib" (5 trials), "Daratumumab" (5 trials) and "Ibrutinib" (4 trials). Other intervention names were less common.

The vast majority of trials in "Dokuz Eylul University Medical Faculty" are 71 trials for "All" genders, 5 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Dokuz Eylul University Medical Faculty". undefined are not yet recruiting, 22 are recruiting, 13 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 34 completed trials in Dokuz Eylul University Medical Faculty, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Dokuz Eylul University Medical Faculty, 0 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 43 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 2 trials that are defined as “Not Applicable".